Eiger BioPharmaceuticals, Inc.
-
Ticker
EIGR
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Palo Alto, California
Eiger is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. Eiger's pipeline includes preclinical NCEs from discovery as well repurposed clinical Rx agents shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. http://www.eigerbio.com
REPORT RATINGS
4.8 / 5.0 (94)
Eiger BioPharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 94 reviews.
Eiger BioPharmaceuticals, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports